Influence of age and renal function on the concentration of rivaroxaban in plasma and urine in patients undergoing primary elective total knee and hip replacement surgery

被引：0
|
作者：
Schulze, Astrid [1 ]
Marx, Svetlana [2 ]
Weiss, Christel [3 ]
Harenberg, Job [2 ]
机构：
[1] Fac Med Mannheim, Dept Orthoped Surg, D-68167 Mannheim, Germany
[2] Fac Med Mannheim, Dept Clin Pharmacol, D-68169 Mannheim, Germany
[3] Fac Med Mannheim, Inst Biometrie & Stat, D-68167 Mannheim, Germany
来源：
THROMBOSIS RESEARCH | 2012年 / 130卷
关键词：
D O I：
10.1016/j.thromres.2012.08.038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [21] Should Chronological Age be a Consideration in Patients Undergoing Elective Primary Total Knee Arthroplasty?
    Lee, Gwo-Chin
    Illescas, Alex
    Fowler, Mia
    Poeran, Jashvant
    Memtsoudis, Stavros
    Liu, Jiabin
    JOURNAL OF ARTHROPLASTY, 2024, 39 (09): : S179 - S184
  • [22] PRIMARY TOTAL HIP OR KNEE REPLACEMENT - EVALUATION OF PATIENTS
    LIANG, MH
    CULLEN, KE
    POSS, R
    ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) : 735 - 739
  • [23] Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement
    Freyburger, Genevieve
    Macouillard, Gerard
    Labrouche, Sylvie
    Sztark, Francois
    THROMBOSIS RESEARCH, 2011, 127 (05) : 457 - 465
  • [24] A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban
    Kwong, Louis M.
    Turpie, Alexander G. G.
    Tamayo, Sally
    Peacock, W. Frank
    Yuan, Zhong
    Sicignano, Nicholas
    Hopf, Kathleen Pillsbury
    Patel, Manesh R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (09) : 1717 - 1723
  • [25] Population Pharmacokinetics of Periarticular Ketorolac in Adult Patients Undergoing Total Hip or Total Knee Replacement Surgery
    Gurunathan, Usha
    Parker, Suzanne L.
    Maguire, Richard
    Ramdath, Dale
    Bijoor, Manu
    Wallis, Steven C.
    Roberts, Jason A.
    ANESTHESIA AND ANALGESIA, 2019, 129 (03): : 701 - 708
  • [26] Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery
    Baser, Onur
    Supina, Dylan
    Sengupta, Nishan
    Wang, Li
    Kwong, Louis
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (02) : 423 - 429
  • [27] Impact of venous thromboemolism in US Medicare patients undergoing total hip and total knee replacement surgery
    Baser, O.
    Supina, D.
    Sengupta, N.
    Wang, L.
    Kwong, L. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 788 - 789
  • [28] Indirect comparisons of rivaroxaban vs alternative prophylaxes for the prevention of venous thromboembolism in patients undergoing total hip or total knee replacement
    Diamantopoulos, A.
    LeReun, C.
    Rasul, F.
    Lees, M.
    Kubin, M.
    VALUE IN HEALTH, 2008, 11 (03) : A197 - A198
  • [29] Clinical experience with rivaroxaban in antiaggregated patients undergoing total hip and knee arthroplasty
    Grappiolo, G.
    Scardino, M.
    Martorelli, F.
    Astore, F.
    Mazziotta, G.
    Ferrari, M.
    Quaini, S.
    MINERVA ORTOPEDICA E TRAUMATOLOGICA, 2013, 64 (06) : 575 - 581
  • [30] Economic comparison of rivaroxaban with dabigatran in canadian patients undergoing total hip replacement
    Wells, P.
    Diamantopoulos, A.
    McDonald, H.
    Forster, F.
    LeReun, C.
    Rasul, F.
    Lees, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 201 - 201
12345